Intravenous Immune Globulin (IVIg) has been approved and used successfully for over 20 years to treat a variety of autoimmune and immunodeficient diseases. Since the late 1990s, there has been increasing evidence that immunotherapy targeting the amyloid beta (Aβ) peptide can be used to treat Alzheimer’s disease (AD). Because it contains anti-amyloid antibodies IVIg is being investigated in a Phase III study as a treatment for Alzheimer’s disease.

U.S. Clinical Study Research Sites Participating in the IVIG Study

 

Site	City	State	Contact	Telephone
University of Alabama, Birmingham	Birmingham	AL	Denise Ledlow	(205)934-6223
Banner Sun Health Research Institute	Sun City	AZ	Zoran Obradov	(623)832-6526
University of California, San Diego	La Jolla	CA
University of California, San Diego	La Jolla	CA	Michelle Herman	(858)246-1305
University of Southern California	Los Angeles	CA	Mauricio Becerra	(323)442-7594
Howard University	Washington	DC	Oludolapo Ogunlana	(202)865-3776
University of South Florida – Health Byrd Alzheimer Institute	Tampa	FL	Kelly Rodrigo	(813)974-4904
University of Iowa	Iowa City	IA	Karen Smith	(319)353-5158
University of Kansas	Kansas City	KS	Rebecca Bothwell	(913)945-5033
University of Kentucky	Lexington	KY	Heather Nichols	(859)323-3145
Bronson Lakeview Hospital	Kalamazoo	MI	Gail Massey	(269)341-8774
Mayo Clinic, Rochester	Rochester	MN	Sara Mason	(507)293-4711
Saint Louis University	St. Louis	MO	Susan Brown	(314)977-4818
University of Nebraska Medical Center	Omaha	NE	Barbara Bayer	(402)552-6007
Cleveland Clinic Lou Ruvo Center for Brain Health	Las Vegas	NV	Michelle Sholar	(702)483-6026
Columbia University	New York	NY	Ruth Tejeda	(212)305-7661
University Hospitals Case Medical Center	Cleveland	OH	Parianne Fatica	(216)464-6474
Tulsa Clinical Research	Tulsa	OK	Christy Lisenbee	(918)743-2349
Oregon Health & Science University	Portland	OR	Elisabeth Loree	(503)494-7615
University of Pennsylvania	Philadelphia	PA	Martha Combs	(215)615-3084
Rhode Island Hospital	Providence	RI	Kerstin Calia	(401)444-9861
Medical University of South Carolina	North Charleston	SC	Arthur Williams	(843)724-2302 ext 6375
University of Texas, Southwestern MC at Dallas	Dallas	TX	Gloria Williams	(214)648-9331
University of Utah	Salt Lake City	UT	Elizabeth Nuttall	(801)587-3694
University of Wisconsin	Madison	WI	Meghan Hackbarth	(608) 265-8765

Canadian Clinical Study Research Sites Participating in the IVIG Study